Evidence map›Paper›PMID 26310808›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2015

Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.

Kathryn J Moore, Katey J Rayner

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kathryn J MooreFrom the Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York (K.J.M.); and Department of Biochemistry, Microbiology & Immunology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (K.J.R.).
Katey J RaynerFrom the Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York (K.J.M.); and Department of Biochemistry, Microbiology & Immunology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (K.J.R.). krayner@ottawaheart.ca.

Funding

MicroRNAs as physiological and pathological regulators of cholesterol homeostasisR01HL108182 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOORE, KATHRYN J · 2011 to 2015
$2.1M
miR-33 Pathway Inhibition for Improving HDL FunctionalityR01HL119047 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOORE, KATHRYN J, RAYNER, KATEY · 2015 to 2018
$1.9M
Canadian Institutes of Health Research MOP130365Canadian Institutes of Health Research MSH130157NHLBI NIH HHS R01 HL108182NHLBI NIH HHS R01HL108182NHLBI NIH HHS R01 HL119047NHLBI NIH HHS R01HL119047
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coated Materials, BiocompatibleGene Expression RegulationAnimalsAntibodies, AntinuclearCoronary RestenosisFemaleGraft Occlusion, VascularHumansMaleMicroRNAsAntibodies, AntinuclearCoated Materials, BiocompatibleMicroRNAs

Identifiers

PMID26310808
PMCPMC4617631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.